|
시장보고서
상품코드
1339231
유전체학용 AI 시장, 점유율, 규모, 동향 및 산업 분석 보고서 : 제공 제품, 기술, 기능, 용도, 최종 사용자, 지역 및 부문별 예측(2023-2032년)AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 유전체학 분야 AI 세계 시장 규모는 2032년까지 167억 5,795만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
유전체 데이터 생성에 필요한 막대한 재정적 지원은 시장 성장을 가속하는 데 중요한 역할을 하고 있습니다. 국립 인간 게놈 연구소(NHGRI)와 같은 기관은 다양한 게놈 데이터 과학 이니셔티브를 지원하기 위해 연간 1억 2,500만 달러 이상의 막대한 자금을 배정함으로써 이러한 성장에 크게 기여하고 있습니다. 이러한 재정적 지원을 통해 연구자와 조직은 방대한 양의 게놈 데이터 세트를 생성하고 축적할 수 있습니다. 게놈 데이터의 양이 증가함에 따라 이 방대한 정보를 효과적으로 분석하고 통찰력을 도출하기 위해 머신러닝과 딥러닝 알고리즘을 포함한 AI 기술에 대한 수요가 증가하고 있습니다.
STRIDES와 같은 이니셔티브를 통한 민간 및 상업용 클라우드와 국립보건원(NIH)과 같은 정부 및 공공 기관과의 협력은 시장 성장을 가속하고 있습니다. 이러한 공동 이니셔티브는 게놈 데이터 호스팅을 위한 스토리지 및 컴퓨팅 인프라를 지원합니다. 이러한 이니셔티브는 게놈 연구에서 생성되는 대량의 게놈 데이터를 처리할 수 있는 확장 가능하고 안전한 플랫폼을 제공합니다. 또한, 이들 기업은 기밀성이 높은 인간 게놈 데이터를 보호하기 위해 강력한 보안 및 개인 정보 보호 조치를 우선적으로 시행하고 있습니다.
유전체학 분야의 AI 시장 보고서 하이라이트
소프트웨어 분야는 게놈 데이터 증가로 인해 향후 몇 년동안 더 빠른 성장이 예상됩니다.
머신러닝 부문은 데이터 양과 복잡성 증가로 인해 가장 큰 매출 비중을 차지했습니다.
유전체 시퀀싱 분야는 DNA 시퀀싱 기술의 발전으로 인해 가장 큰 매출 비중을 차지할 것으로 예상됩니다.
정밀의학은 개인 맞춤형 치료 접근법 증가로 인해 큰 성장률을 보일 것으로 예상됩니다.
제약 및 생명공학 기업들은 신약개발의 가속화로 큰 폭의 성장이 예상됩니다.
북미는 헬스케어 활성화를 위한 정부 이니셔티브 증가로 인해 가장 큰 수익 점유율을 차지할 것으로 예상됩니다. 반면, 유럽은 정부의 프로젝트 자금 지원으로 인해 더 큰 수익 점유율을 차지할 것으로 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 유전체학용 AI 시장 인사이트
- 유전체학용 AI - 업계 현황
- 유전체학용 AI 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTLE 분석
- 유전체학 업계 AI 동향
- COVID-19의 영향 분석
제5장 세계의 유전체학용 AI 시장, 제공 내용별
- 주요 조사 결과
- 서론
- 소프트웨어
- 서비스
제6장 세계의 유전체학용 AI 시장, 기술별
- 주요 조사 결과
- 서론
- 머신러닝
- 기타 기술
제7장 세계의 유전체학용 AI 시장, 기능별
- 주요 조사 결과
- 서론
- 게놈 배열 결정
- 유전자 편집
- 임상 워크플로우
- 예측 유전자 검사 및 예방의학
제8장 세계의 유전체학용 AI 시장, 용도별
- 주요 조사 결과
- 서론
- 진단
- Drug Discovery & Development
- 정밀의료
- 농업 및 동물 연구
- 기타 용도
제9장 세계의 유전체학용 AI 시장, 최종사용자별
- 주요 조사 결과
- 서론
- 제약회사 및 바이오테크놀러지 기업
- 의료 제공업체
- 연구센터/학술기관/정부기관
- 기타 최종사용자
제10장 세계의 유전체학용 AI 시장, 지역별
- 주요 조사 결과
- 서론
- 유전체학용 AI 시장 평가, 지역별, 2019-2032년
- 유전체학용 AI 시장 - 북미
- 북미 : 유전체학용 AI 시장, 제공물별, 2019-2032년
- 북미 : 유전체학용 AI 시장, 용도별, 2019-2032년
- 북미 : 유전체학용 AI 시장, 기술별, 2019-2032년
- 북미 : 유전체학용 AI 시장, 기능별, 2019-2032년
- 북미 : 유전체학용 AI 시장, 최종사용자별, 2019-2032년
- 유전체학용 AI 시장 - 미국
- 유전체학용 AI 시장 - 캐나다
- 유전체학용 AI 시장 - 유럽
- 유럽 : 유전체학용 AI 시장, 제공물별, 2019-2032년
- 유럽 : 유전체학용 AI 시장, 용도별, 2019-2032년
- 유럽 : 유전체학용 AI 시장, 기술별, 2019-2032년
- 유럽 : 유전체학용 AI 시장, 기능별, 2019-2032년
- 유럽 : 유전체학용 AI 시장, 최종사용자별, 2019-2032년
- 유전체학용 AI 시장 - 영국
- 유전체학용 AI 시장 - 프랑스
- 유전체학용 AI 시장 - 독일
- 유전체학용 AI 시장 - 이탈리아
- 유전체학용 AI 시장 - 스페인
- 유전체학용 AI 시장 - 네덜란드
- 유전체학용 AI 시장 - 러시아
- 유전체학용 AI 시장 - 아시아태평양
- 아시아태평양 : 유전체학용 AI 시장, 제공물별, 2019-2032년
- 아시아태평양 : 유전체학용 AI 시장, 용도별, 2019-2032년
- 아시아태평양 : 유전체학용 AI 시장, 기술별, 2019-2032년
- 아시아태평양 : 유전체학용 AI 시장, 기능별, 2019-2032년
- 아시아태평양 : 유전체학용 AI 시장, 최종사용자별, 2019-2032년
- 유전체학용 AI 시장 - 중국
- 유전체학용 AI 시장 - 인도
- 유전체학용 AI 시장 - 일본
- 유전체학용 AI 시장 - 말레이시아
- 유전체학용 AI 시장 - 인도네시아
- 유전체학용 AI 시장 - 한국
- 유전체학용 AI 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 유전체학용 AI 시장, 제공물별, 2019-2032년
- 중동 및 아프리카 : 유전체학용 AI 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : 유전체학용 AI 시장, 기술별, 2019-2032년
- 중동 및 아프리카 : 유전체학용 AI 시장, 기능별, 2019-2032년
- 중동 및 아프리카 : 유전체학용 AI 시장, 최종사용자별, 2019-2032년
- 유전체학용 AI 시장 - 사우디아라비아
- 유전체학용 AI 시장 - UAE
- 유전체학용 AI 시장 - 이스라엘
- 유전체학용 AI 시장 - 남아프리카공화국
- 유전체학용 AI 시장 - 라틴아메리카
- 라틴아메리카 : 유전체학용 AI 시장, 제공물별, 2019-2032년
- 라틴아메리카 : 유전체학용 AI 시장, 용도별, 2019-2032년
- 라틴아메리카 : 유전체학용 AI 시장, 기술별, 2019-2032년
- 라틴아메리카 : 유전체학용 AI 시장, 기능별, 2019-2032년
- 라틴아메리카 : 유전체학용 AI 시장, 최종사용자별, 2019-2032년
- 유전체학용 AI 시장 - 멕시코
- 유전체학용 AI 시장 - 브라질
- 유전체학용 AI 시장 - 아르헨티나
제11장 경쟁 구도
- 확장 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제12장 기업 개요
- Google DeepMind
- IBM Watson Health
- BenevolentAI
- Tempus
- Freenome
- Sophia Genetics
- 23andMe
- DNAnexus
- Recursion Pharmaceuticals
- Verge Genomics
- PathAI
- GNS Healthcare
- Freenome
- Fabric Genomics
- Foundation Medicine
- SOPHiA GENETICS
- Nebula Genomics
- CytoReason
- Genoox
- Genalice
- Deep Genomics
- Owkin
- Genialis
- Gencove
- Helix
- QIAGEN Bioinformatics
- SOPHiA DDM
- WuXi NextCODE
- Genuity Science
- Lifebit
- Envisagenics
- ZS Genetics
- MedGenome
- Cypher Genomics
- PierianDx
- Bluebee
- Repositive
- Precision for Medicine
- Shivom
- Bluegnome
The global AI in genomics market size is expected to reach USD 16,757.95 million by 2032, according to a new study by Polaris Market Research. The report "AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The substantial financial support required to generate genomic data plays a crucial role in driving the market's growth. Institutions like the National Human Genome Research Institute (NHGRI) contribute significantly to this growth by allocating substantial funding, with an annual investment of over $125 million, to support diverse genomic data science initiatives. This financial backing enables researchers and organizations to generate and accumulate extensive genomic datasets. As the volume of genomic data increases, the demand for AI technologies, including machine learning and deep learning algorithms, rises to effectively analyze and derive insights from this vast amount of information.
The collaboration between private & commercial cloud and governmental & public entities, such as the National Institutes of Health (NIH) through initiatives like STRIDES, drives the market's growth. These collaborative initiatives support the storage and computing infrastructure to host genomic data. They provide scalable and secure platforms to handle the large volumes of genomic data generated in genomics research. Additionally, they prioritize implementing robust security and privacy measures to safeguard sensitive human genomic data.
AI in Genomics Market Report Highlights
Software segment is anticipated to witness faster growth in the coming years due to the rise in genomic data.
Machine Learning segment accounted for the largest revenue share owing to the increased volume and complexity of data.
Genome Sequencing segment is projected to experience the largest revenue share due to the advancements in DNA sequencing technologies.
Precision Medicine is expected to witness significant growth rate due to growing personalized treatment approaches.
Pharmaceuticals and Biotech Companies are expected to grow at a substantial rate due to accelerated drug discovery.
North America is projected to witness largest revenue share owing to the rise in government initiatives to promote healthcare. While Europe is expected to grow a larger revenue share owing to the encouragement from the governments by funding the projects.
The global players include: Google DeepMind, QIAGEN Bioinformatics, SOPHiA DDM, WuXi NextCODE, Genuity Science, Lifebit, Envisagenics, ZS Genetics, MedGenome, Cypher Genomics, PierianDx, Bluebee, Repositive, Precision for Medicine, Shivom & Bluegnome.
Polaris Market Research has segmented the AI in Genomics market report based on offering, technology, functionality, application, end user and region:
AI in Genomics, Offering Outlook (Revenue - USD Million, 2019 - 2032)
- Software
- Services
AI in Genomics, Technology Outlook (Revenue - USD Million, 2019 - 2032)
- Machine Learning
- Deep Learning
- Supervised Learning
- Unsupervised Learning
- Reinforcement Learning
- Other Machine Learning Technologies
- Other Technologies
AI in Genomics, Functionality Outlook (Revenue - USD Million, 2019 - 2032)
- Genome Sequencing
- Gene Editing
- Clinical Workflows
- Predictive Genetic Testing & Preventive Medicine
AI in Genomics, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Diagnostics
- Drug Discovery & Development
- Precision Medicine
- Agriculture & Animal Research
- Other Applications
AI in Genomics, End User Outlook (Revenue - USD Million, 2019 - 2032)
- Pharmaceutical and Biotech Companies
- Healthcare Providers
- Research Centres, Academic Institutes and Government Organization
- Other End Users
AI in Genomics, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global AI in Genomics Market Insights
- 4.1. AI in Genomics - Industry Snapshot
- 4.2. AI in Genomics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Exponential growth of biomedical research projects
- 4.2.1.2. Technological advancements and computational power
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Data quality and availability
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. AI in Genomics Industry Trends
- 4.6. COVID-19 Impact Analysis
5. Global AI in Genomics Market, by Offering
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 5.3. Software
- 5.3.1. Global AI in Genomics Market, by Software, by Region, 2019-2032 (USD Million)
- 5.4. Services
- 5.4.1. Global AI in Genomics Market, by Services, by Region, 2019-2032 (USD Million)
6. Global AI in Genomics Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 6.3. Machine Learning
- 6.3.1. Global AI in Genomics Market, by Machine Learning, by Region, 2019-2032 (USD Million)
- 6.3.2. Deep Learning
- 6.3.2.1. Global AI in Genomics Market, by Deep Learning, by Region, 2019-2032 (USD Million)
- 6.3.3. Supervised Learning
- 6.3.3.1. Global AI in Genomics Market, by Supervised Learning, by Region, 2019-2032 (USD Million)
- 6.3.4. Unsupervised Learning
- 6.3.4.1. Global AI in Genomics Market, by Unsupervised Learning, by Region, 2019-2032 (USD Million)
- 6.3.5. Reinforcement Learning
- 6.3.5.1. Global AI in Genomics Market, by Reinforcement Learning, by Region, 2019-2032 (USD Million)
- 6.3.6. Other Machine Learning Technologies
- 6.3.6.1. Global AI in Genomics Market, by Other Machine Learning Technologies, by Region, 2019-2032 (USD Million)
- 6.4. Others Technologies
- 6.4.1. Global AI in Genomics Market, by Others Technologies, by Region, 2019-2032 (USD Million)
7. Global AI in Genomics Market, by Functionality
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 7.3. Genome Sequencing
- 7.3.1. Global AI in Genomics Market, by Genome Sequencing, by Region, 2019-2032 (USD Million)
- 7.4. Gene Editing
- 7.4.1. Global AI in Genomics Market, by Gene Editing, by Region, 2019-2032 (USD Million)
- 7.5. Clinical Workflows
- 7.5.1. Global AI in Genomics Market, by Clinical Workflows, by Region, 2019-2032 (USD Million)
- 7.6. Predictive Genetic Testing & Preventive Medicine
- 7.6.1. Global AI in Genomics Market, by Predictive Genetic Testing & Preventive Medicine, by Region, 2019-2032 (USD Million)
8. Global AI in Genomics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 8.3. Diagnostics
- 8.3.1. Global AI in Genomics Market, by Diagnostics, by Region, 2019-2032 (USD Million)
- 8.4. Drug Discovery & Development
- 8.4.1. Global AI in Genomics Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Million)
- 8.5. Precision Medicine
- 8.5.1. Global AI in Genomics Market, by Precision Medicine, by Region, 2019-2032 (USD Million)
- 8.6. Agriculture & Animal Research
- 8.6.1. Global AI in Genomics Market, by Agriculture & Animal Research, by Region, 2019-2032 (USD Million)
- 8.7. Other Applications
- 8.7.1. Global AI in Genomics Market, by Other Applications, by Region, 2019-2032 (USD Million)
9. Global AI in Genomics Market, by End User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 9.3. Pharmaceutical and Biotech Companies
- 9.3.1. Global AI in Genomics Market, by Pharmaceutical and Biotech Companies, by Region, 2019-2032 (USD Million)
- 9.4. Healthcare Providers
- 9.4.1. Global AI in Genomics Market, by Healthcare Providers, by Region, 2019-2032 (USD Million)
- 9.5. Research Centres, Academic Institutes and Government Organization
- 9.5.1. Global AI in Genomics Market, by Research Centres, Academic Institutes and Government Organization, by Region, 2019-2032 (USD Million)
- 9.6. Other End Users
- 9.6.1. Global AI in Genomics Market, by Other End Users, by Region, 2019-2032 (USD Million)
10. Global AI in Genomics Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. AI in Genomics Market Assessment, By Geography, 2019-2032 (USD Million)
- 10.3. AI in Genomics Market - North America
- 10.3.1. North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.2. North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.3. North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.4. North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.5. North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.3.6. AI in Genomics Market - U.S.
- 10.3.6.1. U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.6.2. U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.6.3. U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.6.4. U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.6.5. U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.3.7. AI in Genomics Market - Canada
- 10.3.7.1. Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.3.7.2. Canada.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.3.7.3. Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.3.7.4. Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.3.7.5. Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4. AI in Genomics Market - Europe
- 10.4.1. Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.2. Europe.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.3. Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.4. Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.5. Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.6. AI in Genomics Market - UK
- 10.4.6.1. UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.6.2. UK.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.6.3. UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.6.4. UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.6.5. UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.7. AI in Genomics Market - France
- 10.4.7.1. France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.7.2. France.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.7.3. France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.7.4. France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.7.5. France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.8. AI in Genomics Market - Germany
- 10.4.8.1. Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.8.2. Germany.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.8.3. Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.8.4. Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.8.5. Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.9. AI in Genomics Market - Italy
- 10.4.9.1. Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.9.2. Italy.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.9.3. Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.9.4. Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.9.5. Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.10. AI in Genomics Market - Spain
- 10.4.10.1. Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.10.2. Spain.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.10.3. Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.10.4. Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.10.5. Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.11. AI in Genomics Market - Netherlands
- 10.4.11.1. Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.11.2. Netherlands.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.11.3. Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.11.4. Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.11.5. Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.4.12. AI in Genomics Market - Russia
- 10.4.12.1. Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.4.12.2. Russia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.4.12.3. Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.4.12.4. Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.4.12.5. Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5. AI in Genomics Market - Asia Pacific
- 10.5.1. Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.2. Asia Pacific.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.3. Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.4. Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.5. Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.6. AI in Genomics Market - China
- 10.5.6.1. China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.6.2. China.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.6.3. China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.6.4. China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.6.5. China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.7. AI in Genomics Market - India
- 10.5.7.1. India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.7.2. India.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.7.3. India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.7.4. India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.7.5. India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.8. AI in Genomics Market - Japan
- 10.5.8.1. Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.8.2. Japan.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.8.3. Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.8.4. Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.8.5. Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.9. AI in Genomics Market - Malaysia
- 10.5.9.1. Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.9.2. Malaysia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.9.3. Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.9.4. Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.9.5. Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.10. AI in Genomics Market - Indonesia
- 10.5.10.1. Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.10.2. Indonesia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.10.3. Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.10.4. Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.10.5. Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.5.11. AI in Genomics Market - South Korea
- 10.5.11.1. South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.5.11.2. South Korea.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.5.11.3. South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.5.11.4. South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.5.11.5. South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6. AI in Genomics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.2. Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.3. Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.4. Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.5. Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.6. AI in Genomics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.6.2. Saudi Arabia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.6.3. Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.6.4. Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.6.5. Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.7. AI in Genomics Market - UAE
- 10.6.7.1. UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.7.2. UAE.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.7.3. UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.7.4. UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.7.5. UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.8. AI in Genomics Market - Israel
- 10.6.8.1. Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.8.2. Israel.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.8.3. Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.8.4. Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.8.5. Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.6.9. AI in Genomics Market - South Africa
- 10.6.9.1. South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.6.9.2. South Africa.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.6.9.3. South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.6.9.4. South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.6.9.5. South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7. AI in Genomics Market - Latin America
- 10.7.1. Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.2. Latin America.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.3. Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.4. Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.5. Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.6. AI in Genomics Market - Mexico
- 10.7.6.1. Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.6.2. Mexico.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.6.3. Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.6.4. Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.6.5. Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.7. AI in Genomics Market - Brazil
- 10.7.7.1. Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.7.2. Brazil.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.7.3. Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.7.4. Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.7.5. Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
- 10.7.8. AI in Genomics Market - Argentina
- 10.7.8.1. Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
- 10.7.8.2. Argentina.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
- 10.7.8.3. Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
- 10.7.8.4. Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
- 10.7.8.5. Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Google DeepMind
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. IBM Watson Health
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. BenevolentAI
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Tempus
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Freenome
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Sophia Genetics
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. 23andMe
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. DNAnexus
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Recursion Pharmaceuticals
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Verge Genomics
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. PathAI
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. GNS Healthcare
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Freenome
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
- 12.14. Fabric Genomics
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development
- 12.15. Foundation Medicine
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development
- 12.16. SOPHiA GENETICS
- 12.16.1. Company Overview
- 12.16.2. Financial Performance
- 12.16.3. Product Benchmarking
- 12.16.4. Recent Development
- 12.17. Nebula Genomics
- 12.17.1. Company Overview
- 12.17.2. Financial Performance
- 12.17.3. Product Benchmarking
- 12.17.4. Recent Development
- 12.18. CytoReason
- 12.18.1. Company Overview
- 12.18.2. Financial Performance
- 12.18.3. Product Benchmarking
- 12.18.4. Recent Development
- 12.19. Genoox
- 12.19.1. Company Overview
- 12.19.2. Financial Performance
- 12.19.3. Product Benchmarking
- 12.19.4. Recent Development
- 12.20. Genalice
- 12.20.1. Company Overview
- 12.20.2. Financial Performance
- 12.20.3. Product Benchmarking
- 12.20.4. Recent Development
- 12.21. Deep Genomics
- 12.21.1. Company Overview
- 12.21.2. Financial Performance
- 12.21.3. Product Benchmarking
- 12.21.4. Recent Development
- 12.22. Owkin
- 12.22.1. Company Overview
- 12.22.2. Financial Performance
- 12.22.3. Product Benchmarking
- 12.22.4. Recent Development
- 12.23. Genialis
- 12.23.1. Company Overview
- 12.23.2. Financial Performance
- 12.23.3. Product Benchmarking
- 12.23.4. Recent Development
- 12.24. Gencove
- 12.24.1. Company Overview
- 12.24.2. Financial Performance
- 12.24.3. Product Benchmarking
- 12.24.4. Recent Development
- 12.25. Helix
- 12.25.1. Company Overview
- 12.25.2. Financial Performance
- 12.25.3. Product Benchmarking
- 12.25.4. Recent Development
- 12.26. QIAGEN Bioinformatics
- 12.26.1. Company Overview
- 12.26.2. Financial Performance
- 12.26.3. Product Benchmarking
- 12.26.4. Recent Development
- 12.27. SOPHiA DDM
- 12.27.1. Company Overview
- 12.27.2. Financial Performance
- 12.27.3. Product Benchmarking
- 12.27.4. Recent Development
- 12.28. WuXi NextCODE
- 12.28.1. Company Overview
- 12.28.2. Financial Performance
- 12.28.3. Product Benchmarking
- 12.28.4. Recent Development
- 12.29. Genuity Science
- 12.29.1. Company Overview
- 12.29.2. Financial Performance
- 12.29.3. Product Benchmarking
- 12.29.4. Recent Development
- 12.30. Lifebit
- 12.30.1. Company Overview
- 12.30.2. Financial Performance
- 12.30.3. Product Benchmarking
- 12.30.4. Recent Development
- 12.31. Envisagenics
- 12.31.1. Company Overview
- 12.31.2. Financial Performance
- 12.31.3. Product Benchmarking
- 12.31.4. Recent Development
- 12.32. ZS Genetics
- 12.32.1. Company Overview
- 12.32.2. Financial Performance
- 12.32.3. Product Benchmarking
- 12.32.4. Recent Development
- 12.33. MedGenome
- 12.33.1. Company Overview
- 12.33.2. Financial Performance
- 12.33.3. Product Benchmarking
- 12.33.4. Recent Development
- 12.34. Cypher Genomics
- 12.34.1. Company Overview
- 12.34.2. Financial Performance
- 12.34.3. Product Benchmarking
- 12.34.4. Recent Development
- 12.35. PierianDx
- 12.35.1. Company Overview
- 12.35.2. Financial Performance
- 12.35.3. Product Benchmarking
- 12.35.4. Recent Development
- 12.36. Bluebee
- 12.36.1. Company Overview
- 12.36.2. Financial Performance
- 12.36.3. Product Benchmarking
- 12.36.4. Recent Development
- 12.37. Repositive
- 12.37.1. Company Overview
- 12.37.2. Financial Performance
- 12.37.3. Product Benchmarking
- 12.37.4. Recent Development
- 12.38. Precision for Medicine
- 12.38.1. Company Overview
- 12.38.2. Financial Performance
- 12.38.3. Product Benchmarking
- 12.38.4. Recent Development
- 12.39. Shivom
- 12.39.1. Company Overview
- 12.39.2. Financial Performance
- 12.39.3. Product Benchmarking
- 12.39.4. Recent Development
- 12.40. Bluegnome
- 12.40.1. Company Overview
- 12.40.2. Financial Performance
- 12.40.3. Product Benchmarking
- 12.40.4. Recent Development
비교리스트